Answers are grounded in this paper and cite their sources.
Retrospective analysis identifies female sex and vasospasm as risk factors for Takotsubo cardiomyopathy in aSAH patients, with unclear clinical implications.
Introduction Takotsubo cardiomyopathy (TCM) is a reversible cardiac syndrome that can develop from severe neurogenic stress following aneurysmal subarachnoid hemorrhage (aSAH). In the modern era of aSAH care, marked by significant advancements in neuroendovascular treatment strategies for cerebral aneurysms, the risk factors and impact of TCM on clinical outcomes remain unclear. The aim of this study was to identify predictors of TCM after aSAH in a contemporary patient cohort and to evaluate the relationship between TCM and discharge disability as well as hospital length of stay (LOS). Methods This was a single‐center, retrospective study that included consecutive aSAH patients admitted between August 2003 to March 2024. Transthoracic echocardiogram (TTE) reports were reviewed, and the modified Mayo Clinic criteria were applied to determine the presence of TCM. Poor functional status at discharge was defined by a modified Rankin Scale (mRS) score ≥ 3. Significant variables identified in univariable tests between patients with and without TCM were included in a multivariable logistic regression model to identify predictors of TCM. Multivariable models adjusted for age, sex, Hunt & Hess scores, baseline mRS scores, and vasospasm, were used to study the association between TCM and poor discharge functional status and LOS. Results Among 374 patients with aSAH (mean age 56±14 years, 67% female), 209 (56%) underwent TTE, of which, 15 (7%) were diagnosed with TCM. The most common regional wall motion abnormality, observed in 7 patients (47%), involved the apical segments. Compared to those without TCM, patients with TCM were more likely to be female (93% vs. 66%, p = 0.04), require acute CSF diversion (93% vs. 68%, p = 0.04), develop vasospasm (87% vs. 52%, p = 0.01), have higher Hunt & Hess scores (4 IQR [4,5] vs. 2 IQR [1,3], p < 0.01), and higher glucose values on admission (182±56 vs. 154±49 mg/dL, p = 0.04). In the multivariable analysis, female sex (OR 13.20, 95% CI [1.55‐112.43], p = 0.02), vasospasm (OR 6.98, 95% CI [1.43‐33.87], p = 0.02), and Hunt & Hess scores (OR 2.04, 95% CI [1.10‐3.80], p = 0.02), remained significantly associated with TCM. 174 (47%) patients had poor discharge functional status, and the mean LOS was 20±12 days. In univariable tests, patients with TCM were more likely to have poor functional status at discharge (10% vs. 2%, p = 0.05) and increased LOS (30±15 vs. 23±13 days, p = 0.04). However, in the multivariable models, TCM was not independently associated with increased discharge disability (OR 2.15. 95% CI [0.40‐11.49], p = 0.37) or longer LOS ( β = 3.209, p = 0.53). Conclusion In this cohort of aSAH patients, female sex, vasospasm, and higher Hunt & Hess scores were significant risk factors for developing TCM. However, TCM did not appear to independently impact clinical outcomes, suggesting that TCM may be a benign clinical entity in the context of aSAH. Future prospective studies with larger patient cohorts and a standardized approach to evaluating TCM are needed to fully elucidate the prognostic implications of TCM after aSAH.
No takes yet. Share an insight, caveat, or question.
Alwakaa et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: